Adalimumab - PDFSEARCH.IO - Document Search Engine

Adalimumab
Results: 358

#	Item
71	November 2013 PBAC Meeting Outcomes - "1st time" decisions not to recommend Drug and Form Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-01-19 17:21:09 Immunosuppressants Monoclonal antibodies Autoimmune diseases Adalimumab Meningococcal disease Ulcerative colitis Vaccination schedule Vaccine Neisseria meningitidis Bacteria Medicine Microbiology
72	Microsoft Word - PBAC agenda for web publication March 2010.doc Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-01-04 21:20:14 Ketones Healthcare in Australia Pharmaceutical Benefits Scheme Pharmaceuticals policy Drug rehabilitation Amines Methadone Adalimumab Omeprazole Chemistry Organic chemistry Pharmacology
73	Interim Clinical Commissioning Policy Statement: Biologic Therapies for the treatment of Juvenile Idiopathic Arthritis (JIA) January 2015 Reference: NHS ENGLAND E03/PS/a Add to Reading List Source URL: www.engage.england.nhs.uk Language: English - Date: 2015-01-30 10:12:19 Immunology Arthritis Autoimmune diseases Rheumatology Monoclonal antibodies Juvenile idiopathic arthritis Adalimumab Rheumatoid arthritis Infliximab Medicine Health Immunosuppressants
74	6.1 ADALIMUMAB 20 mg/0.4 ml injection, 2 x 0.4 ml syringes, 40 mg/0.8 ml injection, 2 x 0.8 ml cartridges, 40 mg/0.8 ml injection, 2 x 0.8 ml syringes, 40 mg/0.8 ml injection, 6 x 0.8 ml cartridges, 40 mg/0.8 ml injec Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-16 01:05:14 Monoclonal antibodies Immunosuppressants Autoimmune diseases Arthritis Immune system Infliximab Adalimumab TNF inhibitor Psoriatic arthritis Medicine Health Pharmacology
75	The Drug Utilisation Sub-Committee (DUSC) of the Pharmaceutical Benefits Advisory Committee (PBAC) held its 83rd meeting on 5-6 February[removed]DUSC is a national focus of excellence in collecting, analysing and interpret Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-13 00:20:02 Medicine Health Healthcare in Australia Pharmaceutical Benefits Scheme Pharmaceuticals policy Quality use of medicines Adalimumab Infliximab Alternative medicine Pharmacology Monoclonal antibodies Immunosuppressants
76	GERIATRIC THERAPEUTICS Editors: Michael Woodward, Director, Aged and Residential Care Services, Benny Katz, Consultant Geriatrician, Rohan Elliott, Clinical Pharmacist, Francine Tanner, Clinical Pharmacist, Austin Health Add to Reading List Source URL: jppr.shpa.org.au Language: English - Date: 2008-06-23 23:54:54 Immunology Rheumatoid arthritis Disease-modifying antirheumatic drug Leflunomide Anakinra Adalimumab Infliximab Arthritis Etanercept Medicine Immunosuppressants Health
77	1 issue Care, Health, Arthritic Management Editorial Add to Reading List Source URL: www.hkarf.org Language: English - Date: 2009-09-17 01:01:48 Immunosuppressants Rheumatology Rheumatoid arthritis Psoriatic arthritis Juvenile idiopathic arthritis Adalimumab Leflunomide Infliximab Osteoarthritis Medicine Health Arthritis
78	infliximab, 100mg, powder for concentrate for solution for infusion (Inflectra®) SMC No[removed]Hospira UK Ltd. 07 November[removed]Issued 06 March[removed]The Scottish Medicines Consortium (SMC) has completed its assess Add to Reading List Source URL: www.scottishmedicines.org.uk Language: English Pharmacology Autoimmune diseases Monoclonal antibodies Arthritis Rheumatology Infliximab Adalimumab Etanercept TNF inhibitor Medicine Health Immunosuppressants
79	Drug Utilisation Sub-Committee Outcome Statement 5 – 6 February 2015 The Drug Utilisation Sub-Committee (DUSC) of the Pharmaceutical Benefits Advisory Committee (PBAC) held its 83rd meeting on 5-6 February[removed]DUSC i Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-13 00:20:02 Medicine Health Healthcare in Australia Pharmaceutical Benefits Scheme Pharmaceuticals policy Quality use of medicines Adalimumab Alternative medicine Infliximab Pharmacology Monoclonal antibodies Immunosuppressants
80	infliximab, 100mg, powder for concentrate for solution for infusion (Remsima®) SMC No[removed]Celltrion Healthcare Hungary Kft. 07 November[removed]Issued 06 March[removed]The Scottish Medicines Consortium (SMC) has comp Add to Reading List Source URL: www.scottishmedicines.org.uk Language: English Immunosuppressants Autoimmune diseases Monoclonal antibodies Arthritis Rheumatology Infliximab Adalimumab Etanercept TNF inhibitor Medicine Health Pharmacology

UPDATE